Neoplastic Processes D009385

Diseases [C] » Neoplasms [C04] » Neoplastic Processes

Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Neoplastic Processes

Description

The pathological mechanisms and forms taken by tissue during degeneration into a neoplasm and its subsequent activity.   MeSH

Hierarchy View

Subtype Terms (8)

Anaplasia
11 drugs (10 approved, 1 experimental)

Carcinogenesis
5 drugs (1 approved, 4 experimental)

Neoplasm Invasiveness
 

Neoplasm Metastasis
745 drugs (310 approved, 435 experimental)

Neoplasm Recurrence, Local
19 drugs (13 approved, 6 experimental)

Neoplasm Regression, Spontaneous
 

Neoplasm, Residual
50 drugs (33 approved, 17 experimental)

Oncogene Addiction
 


Phase 2 Indicated Drugs (1)

Phase 1 Indicated Drugs (1)


Organization Involved with Phase 1 Indications (2)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.